82 related articles for article (PubMed ID: 21590053)
1. Effects of gelonin immunoconjugate of monoclonal antibody MSN-1 to endometrial adenocarcinoma on antigen-producing tumor cells in vitro.
Kaneta Y; Tsukazaki K; Kubushiro K; Aoki R; Sakayori M; Ueda M; Nozawa S
Oncol Rep; 1997; 4(2):331-6. PubMed ID: 21590053
[TBL] [Abstract][Full Text] [Related]
2. Effect of gelonin immunoconjugate with monoclonal antibody MSN-1 to endometrial adenocarcinoma on antigen-producing tumor cells in vivo.
Kaneta Y; Tsukazaki K; Kubushiro K; Aoki R; Sakayori M; Ueda M; Nozawa S
Jpn J Cancer Res; 1998 May; 89(5):583-8. PubMed ID: 9685864
[TBL] [Abstract][Full Text] [Related]
3. Selective cytotoxicity of adriamycin immunoconjugate of monoclonal antibody MSN-1 to endometrial adenocarcinoma in vitro and in vivo.
Kaneta Y; Tsukazaki K; Kubushiro K; Sakayori M; Ueda M; Nozawa S
Oncol Rep; 2000; 7(5):1099-106. PubMed ID: 10948346
[TBL] [Abstract][Full Text] [Related]
4. [Production of monoclonal antibody against a newly established human endometrial cancer cell line SNG-II].
Nozawa S; Sakayori M; Takayama Y; Tsukazaki K; Aoki D; Iizuka R; Mukai M; Inaba N
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):559-66. PubMed ID: 3295079
[TBL] [Abstract][Full Text] [Related]
5. [Characterization of anti human uterine endometrial cancer antibody (MSN-1) and its usefulness in clinical application].
Tsukazaki K; Sakuma Y; Kaneta Y; Sakayori M; Uchiyama M; Nozawa S
Gan To Kagaku Ryoho; 1994 Feb; 21(2):141-9. PubMed ID: 8311483
[TBL] [Abstract][Full Text] [Related]
6. The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin.
Scott CF; Goldmacher VS; Lambert JM; Chari RV; Bolender S; Gauthier MN; Blättler WA
Cancer Immunol Immunother; 1987; 25(1):31-40. PubMed ID: 3496157
[TBL] [Abstract][Full Text] [Related]
7. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody (MSN-1) against a newly established uterine endometrial cancer cell line (SNG-II) and its application to immunohistochemistry and flow cytometry.
Nozawa S; Sakayori M; Ohta K; Iizuka R; Mochizuki H; Soma M; Fujimoto J; Hata J; Iwamori M; Nagai Y
Am J Obstet Gynecol; 1989 Oct; 161(4):1079-86. PubMed ID: 2478021
[TBL] [Abstract][Full Text] [Related]
9. A gelonin-containing immunotoxin directed against human breast carcinoma.
Rosenblum MG; Zuckerman JE; Marks JW; Rotbein J; Allen WR
Mol Biother; 1992 Sep; 4(3):122-9. PubMed ID: 1445665
[TBL] [Abstract][Full Text] [Related]
10. [The mechanism of cytotoxicity of monoclonal antibodies to gynecological cancer cell-lines].
Iida S; Nozawa S
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Jul; 42(7):667-74. PubMed ID: 2212803
[TBL] [Abstract][Full Text] [Related]
11. Subcellular localization of blood group Leb carbohydrate antigen (MSN-1-reactive antigen) in endometrial cancer cells.
Susumu N; Kawakami H; Aoki D; Hirano H; Nozawa S
Cancer Res; 1993 Aug; 53(15):3643-8. PubMed ID: 8339270
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of a monoclonal antibody (MSN-3) for uterine endometrial and endocervical adenocarcinoma.
Hasegawa K; Tsukazaki K; Kubushiro K; Kobayashi Y; Kobiki K; Udagawa Y; Nozawa S
Int J Oncol; 1997 Oct; 11(4):749-56. PubMed ID: 21528270
[TBL] [Abstract][Full Text] [Related]
13. c-erbB-2/p185-directed therapy in human lung adenocarcinoma.
Snider JM; Bushnell LJ; Chen LC; Lanza LA
Ann Thorac Surg; 1996 Nov; 62(5):1454-9. PubMed ID: 8893583
[TBL] [Abstract][Full Text] [Related]
14. Expression mechanism of human uterine endometrial cancer-specific fucosylated carbohydrate chains - aberrant alpha-1-]4-fucosyl-transferases in uterine endometrial cancer-derived cell-lines with type-I carbohydrate chain.
Kubushiro K; Tsukazaki K; Sakuma Y; Akiba Y; Sakayori M; Aoki R; Yazawa S; Nozawa S
Int J Oncol; 1995 Jan; 6(1):93-7. PubMed ID: 21556507
[TBL] [Abstract][Full Text] [Related]
15. A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin.
Rosenblum MG; Murray JL; Cheung L; Rifkin R; Salmon S; Bartholomew R
Mol Biother; 1991 Mar; 3(1):6-13. PubMed ID: 1906286
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies raised against cultured cells and their application in cancer diagnosis].
Nozawa S; Udagawa Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1858-63. PubMed ID: 2730079
[TBL] [Abstract][Full Text] [Related]
17. [Abnormal expression of glycoconjugate associated with the development of endometrial cancer: a basic study and its usefulness in clinical application].
Tsukazaki K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):789-801. PubMed ID: 8371008
[TBL] [Abstract][Full Text] [Related]
18. [Abnormal expression of carbohydrate chain and its mechanism in endometrial cancer].
Kubushiro K; Tsukazaki K; Sakuma Y; Nozawa S
Nihon Rinsho; 1995 Jul; 53(7):1753-9. PubMed ID: 7630016
[TBL] [Abstract][Full Text] [Related]
19. Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.
Pagliaro LC; Liu B; Munker R; Andreeff M; Freireich EJ; Scheinberg DA; Rosenblum MG
Clin Cancer Res; 1998 Aug; 4(8):1971-6. PubMed ID: 9717827
[TBL] [Abstract][Full Text] [Related]
20. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
Rosenblum MG; Marks JW; Cheung LH
Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
